GE gets FDA priority review for imaging agent (Reuters)

[riky]

GE gets FDA priority review for imaging agent
    (Reuters)

 


Reuters - GE Healthcare, a unit of General
Electric Corp, said on Thursday U.S. health regulators granted
it priority review on its application for AdreView, a molecular
imaging agent for the detection of neuroendocrine tumors in
children and adult patients.


You are not allowed to view links. Register or Login/news.yahoo.com/s/nm/20080612/sc_nm/gehealth_dc